| Revision as of 08:34, 16 December 2024 editIuliusnanus (talk | contribs)Extended confirmed users562 editsm Iuliusnanus moved page Wen Shuhao to Shuhao Wen: Shuhao Wen is the order by himself in linkedin← Previous edit | Latest revision as of 20:32, 23 December 2024 edit undoTassedethe (talk | contribs)Autopatrolled, Administrators1,364,896 edits added Category:Living people using HotCat | ||
| (4 intermediate revisions by 3 users not shown) | |||
| Line 40: | Line 40: | ||
| In 2015, during his postdoc fellowship at MIT, Wen Shuhao co-founded XtalPi in Boston with two other quantum physicists from MIT, and served as Chairman of the Board. The company combines ], AI, cloud computing, and large-scale robotics experiments to provide R&D solutions, services, and products for pharmaceuticals, biotechnology, renewable energy, and advanced materials industries globally.<ref name=":2">{{Cite web |title=温书豪 |url=https://www.fortunechina.com/detail/people/4040/2020/60/wenshuhao.htm |access-date=2024-12-16 |website=财富中文网 |language=zh-CN}}</ref> | In 2015, during his postdoc fellowship at MIT, Wen Shuhao co-founded XtalPi in Boston with two other quantum physicists from MIT, and served as Chairman of the Board. The company combines ], AI, cloud computing, and large-scale robotics experiments to provide R&D solutions, services, and products for pharmaceuticals, biotechnology, renewable energy, and advanced materials industries globally.<ref name=":2">{{Cite web |title=温书豪 |url=https://www.fortunechina.com/detail/people/4040/2020/60/wenshuhao.htm |access-date=2024-12-16 |website=财富中文网 |language=zh-CN}}</ref> | ||
| In June 2024, XtalPi successfully went public on the ] (HKEX) and made history as the first IPO under HKEX's new Chapter 18C listing rules |
In June 2024, XtalPi successfully went public on the ] (HKEX) and made history as the first IPO under HKEX's new Chapter 18C listing rules for Specialized Technology Companies. <ref name=":1" />XtalPi was the first "AI drug discovery" IPO and the first "AI+robotics" ] in Greater China. Within three months of its listing, the company achieved a market capitalization of HKD 50 billion.<ref>{{Cite web |title=XtalPi Holdings Limited (2228.HK) |url=https://finance.yahoo.com/quote/2228.HK/history/?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAABUAd5J9wW4_fQbBBPvtdh1H0q_xggm8gSfRmrfH0EeKf06OnF-DoA2PInIgMnW6qLrpYY1Q52XYtBjDuYyJ0Sfgga3nj9IfGqw9RXxFEj1PU87y5_gz9fNTWqi_ |website=Yahoo! Finance}}</ref> | ||
| Wen is also an angel investor. Through incubation, investments, and collaboration with XtalPi, Wen helped launch over a dozen startups in life sciences and new materials, including METiS Pharmaceuticals, Signet Therapeutics, Leman Biotech, and META Pharmaceuticals Inc.<ref>{{Cite web |title=As China's First AI Pharmaceutical Company Goes Public, Investors Are Still Cautious - Caixin Global |url=https://www.caixinglobal.com/2024-07-27/weekly-preview-the-first-ai-pharmaceutical-company-goes-public-why-are-investors-still-cautious-about-this-sector-102220619.html |access-date=2024-12-16 |website=www.caixinglobal.com |language=en}}</ref> | Wen is also an angel investor. Through incubation, investments, and collaboration with XtalPi, Wen helped launch over a dozen startups in life sciences and new materials, including METiS Pharmaceuticals, Signet Therapeutics, Leman Biotech, and META Pharmaceuticals Inc.<ref>{{Cite web |title=As China's First AI Pharmaceutical Company Goes Public, Investors Are Still Cautious - Caixin Global |url=https://www.caixinglobal.com/2024-07-27/weekly-preview-the-first-ai-pharmaceutical-company-goes-public-why-are-investors-still-cautious-about-this-sector-102220619.html |access-date=2024-12-16 |website=www.caixinglobal.com |language=en}}</ref> | ||
| ==Awards and |
==Awards and honors== | ||
| * ] China's list of the “40 Business Elites Under 40 (2020)”<ref name=":2" /> | * ] China's list of the “40 Business Elites Under 40 (2020)”<ref name=":2" /> | ||
| * In 2021, Wen was awarded with “] Patent Award”.<ref name=":0" /> | * In 2021, Wen was awarded with “] Patent Award”.<ref name=":0" /> | ||
| * In 2022, Wen was named one of the “Top 10 Outstanding Young Entrepreneurs of Shenzhen”<ref>{{Cite web |title=骄傲！石城人温书豪获选 |
* In 2022, Wen was named one of the “Top 10 Outstanding Young Entrepreneurs of Shenzhen”<ref>{{Cite web |title=骄傲！石城人温书豪获选"深圳市十大杰出青年企业家"_晶泰_科技_研究 |url=https://www.sohu.com/a/675272434_121123848 |access-date=2024-12-16 |website=www.sohu.com}}</ref> | ||
| ==References== | ==References== | ||
| Line 55: | Line 55: | ||
| ] | ] | ||
| ] | ] | ||
| ] | |||
Latest revision as of 20:32, 23 December 2024
| 温书豪 | |
|---|---|
 Wen Shuhao | |
| Born | 1981 (age 42–43) China |
| Occupation(s) | Entrepreneur, scientist |
Shuhao Wen (Simplified Chinese: 温书豪, born 1981) is a Chinese entrepreneur and scientist, who is the chairman and the co-founder of XtalPi Inc. (2228.HK).
Education and Scholarly Activities
Wen is a quantum physicist with a significant computational physics and quantum chemistry background. He has published 36 papers which garnered more than 2,900 citations.
Wen earned his PhD in Physical chemistry from the Chinese Academy of Sciences and went on to pursue postdoctoral research at the University of California Riverside and the Massachusetts Institute of Technology (MIT) before he co-founded XtalPi.
Between 2018-2021, he served as a visiting professor at Zhejiang University.
In 2024, he was nominated by the MIT president to MIT's Visiting Committee for the Chemistry Department.
Entrepreneurship
In 2015, during his postdoc fellowship at MIT, Wen Shuhao co-founded XtalPi in Boston with two other quantum physicists from MIT, and served as Chairman of the Board. The company combines quantum physics, AI, cloud computing, and large-scale robotics experiments to provide R&D solutions, services, and products for pharmaceuticals, biotechnology, renewable energy, and advanced materials industries globally.
In June 2024, XtalPi successfully went public on the Hong Kong Stock Exchange (HKEX) and made history as the first IPO under HKEX's new Chapter 18C listing rules for Specialized Technology Companies. XtalPi was the first "AI drug discovery" IPO and the first "AI+robotics" IPO in Greater China. Within three months of its listing, the company achieved a market capitalization of HKD 50 billion.
Wen is also an angel investor. Through incubation, investments, and collaboration with XtalPi, Wen helped launch over a dozen startups in life sciences and new materials, including METiS Pharmaceuticals, Signet Therapeutics, Leman Biotech, and META Pharmaceuticals Inc.
Awards and honors
- Fortune China's list of the “40 Business Elites Under 40 (2020)”
- In 2021, Wen was awarded with “Shenzhen Patent Award”.
- In 2022, Wen was named one of the “Top 10 Outstanding Young Entrepreneurs of Shenzhen”
References
- ^ "Shuhao WEN - Future Forum". www.futureforum.org.cn. Retrieved 2024-12-16.
- "Wen ShuHao 温书豪". scholar.google.com. Retrieved 2024-12-16.
- sina_mobile (2024-09-29). "AI制药第一股拥抱新能源". finance.sina.cn. Retrieved 2024-12-16.
- ^ "Department of Chemistry – The MIT Corporation". corporation.mit.edu. Retrieved 2024-12-16.
- ^ "温书豪". 财富中文网 (in Chinese (China)). Retrieved 2024-12-16.
- "XtalPi Holdings Limited (2228.HK)". Yahoo! Finance.
- "As China's First AI Pharmaceutical Company Goes Public, Investors Are Still Cautious - Caixin Global". www.caixinglobal.com. Retrieved 2024-12-16.
- "骄傲！石城人温书豪获选"深圳市十大杰出青年企业家"_晶泰_科技_研究". www.sohu.com. Retrieved 2024-12-16.